Research And Markets Research And Markets
0 CHECKOUT

Search for: "Cancer - Brain Tumor"

Brain Tumor - Pipeline Review, H2 2014

Brain Tumor - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Brain Tumor - Pipeline Review, H2 2014’, provides an overview of the Brain Tumor’s therapeutic pipeline. This report provides...

Published:  July 2014
Price:  From EURUSDGBP

Brain Tumor - Pipeline Review, H1 2014

Brain Tumor - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Brain Tumor - Pipeline Review, H1 2014’, provides an overview of the Brain Tumor’s therapeutic pipeline. This report provides...

Published:  February 2014
Price:  From EURUSDGBP

Brain Tumor – Pipeline Review, H1 2013

Global Markets Direct’s, 'Brain Tumor - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline This report provides information on the therapeutic development for Brain...

Published:  February 2013
Price:  From EURUSDGBP

Brain Tumor - Pipeline Review, H2 2013

Brain Tumor - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Brain Tumor - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  July 2013
Price:  From EURUSDGBP

Neuroendocrine Tumors: Analytical Tool

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals...

Published:  August 2016
Price:  From EURUSDGBP

Metastatic Brain Tumor-Pipeline Insights, 2016

“Metastatic Brain Tumor-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Metastatic Brain Tumor. The Report covers the product...

Published:  August 2016
Price:  From EURUSDGBP

Brain Tumor-Pipeline Insights, 2016

“Brain Tumor-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Brain Tumor. The Report covers the product profiles in various stages...

Published:  August 2016
Price:  From EURUSDGBP

Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Our Report, “Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  September 2016
Price:  From EURUSDGBP

Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Our Report, “Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their...

Published:  September 2016
Price:  From EURUSDGBP

Metastatic Brain Tumor - Pipeline Review, H2 2012

Metastatic Brain Tumor – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Metastatic Brain Tumor - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline....

Published:  October 2012
Price:  From EURUSDGBP

Treatment of Atypical Teratoid/Rhabdoid Tumor - Patent Overview in the years 2011 - 2016

Up until 15 or 20 years ago, many didn’t even know what ATRT was. They thought it was just a medulloblastoma because they look similar under the microscope. But now they know that it’s very different...

Published:  June 2016
Price:  EURUSDGBP

Treatment of Pituitary Tumor - Patent Overview in the years 2011 - 2016

A pituitary tumor is an abnormal growth in the pituitary gland. The pituitary is a small gland at the base of the brain. It regulates the body's balance of many hormones. Pituitary tumors are common...

Published:  June 2016
Price:  EURUSDGBP

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline Review, H1 2016

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline Review, H1 2016 Summary ‘Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline Review, H1 2016’, provides an overview of the Peripheral...

Published:  May 2016
Price:  From EURUSDGBP

Brain Tumor - Pipeline Review, H2 2012

Brain Tumor – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Brain Tumor - Pipeline Review, H2 2012', provides an overview of the Brain Tumor therapeutic pipeline. This report provides...

Published:  July 2012
Price:  From EURUSDGBP

Metastatic Brain Tumor - Pipeline Review, H1 2012

Metastatic Brain Tumor – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Metastatic Brain Tumor - Pipeline Review, H1 2012', provides an overview of the Metastatic Brain Tumor therapeutic...

Published:  April 2012
Price:  From EURUSDGBP

Metastatic Brain Tumors - Pipeline Review, H2 2011

Metastatic Brain Tumors - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Metastatic Brain Tumors - Pipeline Review, H2 2011', provides an overview of the Metastatic Brain Tumors therapeutic...

Published:  August 2011
Price:  From EURUSDGBP

Metastatic Brain Tumors - Pipeline Review, Q2 2011

Metastatic Brain Tumors - Pipeline Review, Q2 2011 Summary Global Markets Direct’s, 'Metastatic Brain Tumors - Pipeline Review, Q2 2011', provides an overview of the Metastatic Brain Tumors therapeutic...

Published:  April 2011
Price:  From EURUSDGBP

Metastatic Brain Tumors - Pipeline Review, Q4 2010

Metastatic Brain Tumors - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Metastatic Brain Tumors Pipeline Review, Q4 2010”, provides an overview of the Metastatic Brain Tumors therapeutic...

Published:  December 2010
Price:  From EURUSDGBP

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

Published:  September 2016
Price:  From EURUSDGBP

State of the Art Brain Tumor Diagnostics, Imaginig, and Therapeutics, An Issue of Neuroimaging Clinics. The Clinics: Radiology 20-3

This Neuroimaging publication presents information in three distinct sections: Diagnostics, Planning/Imaging, and Therapeutics. Topics include State of the Art Pathology (New tools, New WHO classification/implications);...

Published:  October 2010
Price:  EURUSDGBP
Loading Indicator